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ABSTRACT 
Objective: To develop and validate new, selective spectrophotometric colorimetric analytical methods for the quantification of methimazole in its 
pure form and in its pharmaceutical preparations.  
Methods: Method A is based on the oxidation of methimazole with potassium permanganate in alkaline medium, the manganate ion produced was 
measured at λ
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max= 610 nm. Method B is a kinetic determination of methimazole using fixed-time method based on the oxidation of methimazole using known 
excess of cerium (IV) nitrate in acidic medium and assessing the unreacted Ce (IV) by adding a fixed amount of methyl orange and measuring the absorbance 
of the resultant solution at λmax
Keywords: Methimazole, Spectrophotometric methods, Potassium permanganate, Cerium (IV) nitrate, Methyl orange 
=507 nm which is equivalent to the unreacted methyl orange. The reaction conditions and analytical parameters are 
investigated and optimized. Method validation was carried out according to ICH guidelines in terms of linearity, LOD, LOQ, precision, and accuracy.  
Results: Beer’s law is obeyed in the range of 1.50–15.00 μg/ml for method A and 0.25–3.00 μg/ml for method B. The developed methods were 
subjected to the detailed validation procedure. The proposed spectrophotometric methods were applied for the determination of the methimazole 
in its pure form and in its pharmaceutical formulation. The percentage recoveries were found to be 100.82 % and 99.85 % in the pharmaceutical 
formulation for the two proposed methods, respectively. 
Conclusion: Both developed spectrophotometric methods, considered as green analytical chemistry, were found to be novel, highly selective and 
can be applied for the quality control of methimazole in its pure form and in its pharmaceutical formulation based on the simplicity, applicability of 
the parameters, accessibility of the reagents employed and reasonably low time of analysis.  
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open-access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
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INTRODUCTION 
Methimazole is an imidazole drug used in the management of 
hyperthyroidism. In the USP, methimazole has been assayed by 
silver nitrate precipitation method [1]. Various methods based on 
different analytical procedures have been described in literature for 
the determination of methimazole including Ultraviolet-Visible (UV-
Vis) spectrophotometry [2-7], derivative spectrophotometry [8], 
Raman spectroscopy [9, 10], resonance light scattering spectroscopy 
[11], chemiluminescence [12-14], fluorescence [15, 16], capillary 
electrophoresis [17], immunoassay [18], molecularly imprinted 
biomimetic sensing [19], Thin Layer Chromatography (TLC) [20] 
and High Performance Liquid Chromatography (HPLC) [21-25]. 
Methimazole has been also determined using electrochemical 
methods by using different chemically modified electrodes through 
introducing various electron mediators on its surface [26-33].  
The UV-Vis spectrophotometer is a simple, low-cost instrument. From 
literature, there are no visible spectrophotometric methods reported 
for the determination of methimazole using Potassium permanganate 
nor Cerium (IV) nitrate which encouraged us to develop these 
methods. In alkaline medium, potassium permanganate is reduced to 
manganate on which absorbs maximally at 610 nm, whose absorbance 
is proportional to the concentration of the drug under study [34-36]. 
However, in acidic medium Cerium (IV) nitrate is one of the most 
important oxidants. The use of cerium (IV) as an oxidant is either 
based on the decrease in its yellow colour or indirect measurement of 
excess cerium (IV) by a reaction with a colour developing dye or 
reagent. The first method being measured in the UV-region gives rise 
for several interferences by UV interfering molecules while adopting 
the second method and measuring in the visible region eliminates such 
interferences [37-40].  
The aim of the present work was to report new, simple and 
environment-friendly spectrophotometric methods for the 
determination of methimazole in pure and in pharmaceutical 
formulations that could be considered superior in comparison with 
the previously reported methods. 
 
 
Fig. 1: Structure of methimazole 
 
MATERIALS AND METHODS 
Chemicals and materials  
Methimazole was certified to contain 98.9 % (Pharmaline, Lebanon). 
Tapazole® tablets (Pharmaline, Lebanon), labeled to contain 5 mg 
methimazole were purchased. 
All chemicals and reagents used were of analytical grade; 
Ammonium Cerium (IV) nitrate (AnalaR), H2SO4 (Avonchem, 98 %), 
KMnO4
Instrumentation 
 (Fluka), Methyl orange (Aldrich chemicals, dye content ≈75  
%), NaOH (Scott Science UK, purity 98-99 %), distilled water was 
produced in-house. 
Jasco V-730 double beam UV-Vis Spectrophotometer interfaced with 
a computer programmed with Jasco Spectra Manager software that 
was used for spectrophotometric measurements, spectral 
acquisition, and elaboration. A pair of 1 cm quartz cells were used to 
measure the absorption spectra.  
International Journal of Pharmacy and Pharmaceutical Sciences 
Print ISSN: 2656-0097 | Online ISSN: 0975-1491                          Vol 12, Issue 2, 2020 
Bathish et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 2, 62-69 
63 
Preparation of solutions 
Standard stock solution 
Methimazole standard stock solution having the concentrations of 
500 µg/ml was prepared using distilled water as a solvent. 
Working standard solution 
A calculated volume of methimazole standard stock solution was 
diluted with distilled water to obtain a concentration of 50µg/ml for 
the working standard solution. 
Reagents 
Sodium hydroxide solution (NaOH 0.5 M) was prepared by 
accurately transferring 20g of NaOH into a 1 L volumetric flask. The 
pellets were dissolved and diluted to volume with distilled water. 
Potassium permanganate solution (KMnO4 0.005 M) was freshly 
prepared by accurately transferring 79 mg of KMnO4 into a 100-mL 
volumetric flask. The powder was dissolved and diluted to volume 
with distilled water. 
Sulphuric acid solution (H2SO4 0.5 M) was prepared by diluting 
27.18 ml of concentrated sulfuric acid (98 %) with distilled water in 
a 1 L volumetric flask.  
Ammonium Cerium (IV) nitrate solution (50 mg %) was freshly 
prepared by accurately weighing 50 mg of Ammonium Cerium (IV) 
nitrate. The powder was dissolved and diluted to volume with 0.5 M 
H2SO4
Recommended procedure 
 in a 100-mL volumetric flask. 
Methyl orange solution (5 mg %) was freshly prepared by accurately 
weighing 6.7 mg of methyl orange with dye content ≈ 75  %. The 
powder was dissolved and diluted to volume with distilled water in 
a 100-mL volumetric flask. 
Method A 
Aliquots of methimazole working standard solution were 
transferred into a series of 10-ml volumetric flasks to cover the 
concentration range stated in table 5. A volume of 1.5 ml of 0.5 M 
NaOH followed by 2 ml of 0.005 M KMnO4
Method B 
 was added to each flask, 
mixed well and completed to volume with distilled water. The 
absorbance values of the resultant mixtures were measured at 610 
nm after 2 min against a blank prepared similarly. 
Aliquots of methimazole working standard solution were 
transferred into a series of 10-ml volumetric flasks to cover the 
concentration range stated in table 5. To each volumetric flask, 1 ml 
of 50 mg % Ammonium Cerium (IV) nitrate solution was added. The 
solutions were mixed well and set aside in darkness for 30 min with 
occasional swirling. Afterward, 1.2 ml of 5 mg % methyl orange 
solution was added to each volumetric flask. After 5 min, the volume 
was diluted to the mark with distilled water. The absorbance value 
of each solution was measured against distilled water as blank at 
507 nm.  
Application to a pharmaceutical preparation 
Ten Tapazole®
Method validation 
 tablets were accurately weighed and finely 
powdered. For Method A, a weight equivalent to 5 mg methimazole 
was dissolved in 10 ml methanol, filtered using Whatman No. 41 
filter paper, a volume of 10 ml distilled water was added, the 
resulting solution was then evaporated using a 70 °C set water bath 
to a volume of 5 ml. The solution was then quantitatively diluted 
with distilled water to obtain a solution within the calibration range 
for the analysis. For Method B, a weight equivalent to 5 mg 
methimazole was dissolved with distilled water and diluted to 100 
ml with distilled water. The obtained solution was then filtered 
using Whatman No. 41 filter paper. A convenient aliquot was then 
considered for the analysis using the proposed method. The amount 
of methimazole present in the tablet was determined by fitting the 
resulting absorbance value into the calculated regression equation. 
Under the optimized experimental conditions, the developed methods 
were validated in accordance to the procedures described in ICH 
guidelines for the following parameters [41]: Linearity, limit of 
detection (LOD), limit of quantitation (LOQ), precision and accuracy. 
Linearity, concentration range, the limit of detection and limit 
of quantitation  
Linearity was determined in the concentration range of 1.5-15 
µg/ml and 0.25-3 µg/ml for methimazole in method A and B 
respectively. 
LOD and LOQ were calculated according to the ICH guidelines by 
using the following formula [41]: 
LOD = 3.3 Sy/x/b 
LOQ = 10 Sy/x/b 
Where “Sy/x
Accuracy and precision  
” is the standard deviation of the regression 
line/residuals and “b” is the slope of the calibration curve. 
In order to assess the accuracy of the proposed methods, the % recovery 
of methimazole using the standard addition method at three different 
concentration levels within the linearity range was determined. 
The precision of the proposed methods was assessed by intra-day 
and inter-day variation studies. The precision was expressed in the 
form of a percentage relative standard deviation (%RSD). During 
intra-day studies, three sample solutions of each concentration were 
analysed on the same day whereas inter-day studies were 
determined by analysing three sample solutions of each 
concentration for three consecutive days.  
RESULTS AND DISCUSSION 
Method A 
The oxidation reaction between methimazole and KMnO4
 
 in alkaline 
medium yields the green-colored manganate radical which absorbs 
maximally at 610 nm (fig. 2). 
 
Fig. 2: Absorption spectrum of 15 µg/ml of methimazole with 2 ml 0.005 M KMnO4 and 1.5 ml 0.5 M NaOH 
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Optimization of reaction conditions 
Experimental conditions affecting color development were 
optimized by fixing all conditions and changing one variable at a 
time. It was found that 2 ml of 0.005 M KMnO4 
Mechanism of the reaction 
and 1.5 ml of 0.5 M 
NaOH were adequate for stable and maximum absorbance. 
The stoichiometry of the reaction between Methimazole and KMnO4 
in alkaline medium was determined by adopting the limiting 
logarithmic method [42]. Two sets of experiments were performed. 
The first set of experiments was carried out using increasing 
concentrations of methimazole (8.76×10-6-1.3×10-4M) at fixed 
permanganate concentration (1.5×10-3 M). The second set of 
experiments was carried out using increasing concentrations of 
permanganate (2.5×10-4-1.5×10-3 M) at fixed methimazole 
concentration (1.3×10-4 M). The logarithms of the absorbance values 
were plotted against the logarithms of the methimazole and KMnO4
fig. 3
 
concentration in the first and second set of experiments, 
respectively. Two straight lines were obtained. The slopes of the 
fitting lines were calculated ( ). 
For the calculation of the ratio of the reaction between Methimazole 
and KMnO4 in alkaline medium, the slope of KMnO4 curve was 
divided by the slope of the drug curve. It was found that the ratio 
was 1.439:1.13 pointing out to a ratio of 1:1 (KMnO4
 
 to 
Methimazole). Accordingly, the reaction pathway is suggested to 
proceed as [7]: 
 
Fig. 3: Limiting logarithmic plot for molar reactivity of methimazole with potassium permanganate 
 
 
Fig. 4: Suggested mechanism for the oxidation of methimazole by KMnO4 in alkaline medium 
 
According to the suggested mechanism of oxidation, the method is based 
on the presence of the thiol group which is oxidized by the MnO4-/OH-
Kinetics of the reactions 
system, therefore the absence of this group will retard the reaction 
pathway. So, it can be concluded that this method can be considered as a 
stability-indicating method for methimazole determination (7). 
It was evident from fig. 5 that the reaction was rapid and became 
more or less constant after 2 min pointing out to the difficulty to 
determine the kinetics of the reaction. 
 
 
Fig. 5: Effect of time on the absorbance value of the reaction product of 15 µg/ml methimazole at 610 nm 
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Method B 
In this method, Methimazole was allowed to react with a known 
excess of Ce (IV) nitrate in acidic medium. The unreacted Ce (IV) 
was reacted with excess methyl orange and the residual methyl 
orange was determined by absorbance measurement at λ max 
fig. 6
507 
nm [40]. In the presence of increasing amounts of the oxidant Ce 
(IV), the absorbance values of methyl orange decreases. Once the 
oxidation reaction is assured complete; the unreacted Ce (IV) 
amount is inversely proportional to the methimazole amount in 
the sample. According to the scheme below, with increased 
methimazole concentration, the amount of unreacted Ce (IV) 
bleaching methyl orange was less and thus the solution 
absorbance value increases linearly with methimazole 
concentration ( ). 
The proposed reaction mechanism scheme of the indirect 
determination of methimazole by oxidation with Ce (IV) is shown 
below [40]: 





Optimization of reaction conditions 
+MOMO oxidation product+unreacted Methyl orange 
It was found that 1 ml of 50 mg % cerium (IV) nitrate in acidic 
medium followed by 1.2 ml of 5 mg % methyl orange solution after 
30 min at room temperature were optimum to get the stable and 
maximum color intensity. 
Kinetics of the reactions 
The rate of the reaction was dependent on methimazole 
concentration. Under the optimum conditions described above, the 
absorbance-time curve was constructed with various drug 
concentrations in the range of 1-3 µg/ml. Both Ce (IV) and methyl 
orange were kept at their optimal concentration of 5 mg % and 0.6 
mg %, respectively. 
 
 
Fig. 6: Absorption spectra of solutions containing (___) 0.6 mg% methyl orange (MO);(….) 0.6 mg% MO+5 mg% Ce (IV) and (---) 0.6 mg% 
MO+5 mg% Ce (IV)+1.7 µg/ml methimazole 
 
 
Fig. 7: Absorbance-time curve for the oxidation reaction of methimazole (1-3 µg/ml) by Ce (IV) in acidic medium 
 
From the graphs shown (fig. 7), the rate increases with increasing 
methimazole concentration, indicating that the reaction rate obeys 
the rate law equation stating:  
Rate = k′[C]n 
Where k΄ is the pseudo-order rate constant and n is the order of the 
reaction. 
From the graphs shown (fig. 7), the rate of the reaction may be 
estimated by the variable-time method, measured as ΔA/Δt where A 
is the absorbance value and t is the time in seconds. Taking 
logarithms of rates and concentrations, the equation is transformed 
into:  
log rate = log k′ + n log C 
Regression of log (rate) versus log [C] by least square method 
generates the calibration equation of:  
log rate =  1.024 log C + 1.424         r = 0.997 
With k΄ = 26.55 s-1, correlation coefficient (r) = 0.997 and the reaction is 
pseudo first order (n ≈ 1) with respect to methimazole (fig. 8). 
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Fig. 8: Log rate versus Log C of methimazole 
 
Under the optimized conditions, the quantitation of methimazole 
would result in pseudo-first-order reaction rate with respect to its 
concentration. However, the reaction is pseudo-zero order with 
respect to Ce (IV) and methyl orange as methimazole concentration 
was determined using an excess amount of Ce (IV) and methyl 
orange, 5 mg % and 0.6 mg %, respectively. 
Therefore, the rate will be directly proportional to methimazole 
concentration in a pseudo-first-order rate equation as follows:  
Rate = k′[C]n 
Where k΄ is the pseudo-first-order rate constant. 
This equation was the core equation for several experiments that 
were conducted to obtain methimazole concentration. For this 
reason, the rate constant, initial rate, fixed absorbance, and fixed-
time methods were performed. Based on the applicability, the 
sensitivity, the correlation coefficient (r) and the intercept, the most 
suitable analytical method was selected. 
Rate constant method 
It was performed by plotting graphs of logarithms of absorbance 
values versus time for different methimazole concentrations in the 
range of 1-3 µg/ml. rectilinear graphs were obtained having a slope 
of the line k΄/-2.303. Pseudo-first-order rate constants 
corresponding to different methimazole concentration were 
calculated from slopes and are presented in table 1. 
Regression of methimazole concentration versus k΄ gave the 
following equation:  
k′ = 98.46 C − 0.019         r = 0.257 
The value of the correlation coefficient (r) indicates poor linearity 
which is probably due to inconsistency of k΄ making the method not 
applicable. 
Initial rate method 
The initial rate of reaction would follow a pseudo order rate 
constant and obey the following rate equation:  




It was determined by measuring the initial tangents of the 
absorbance–time curves slopes at different concentration levels 
(table 2). 
 
Table 1: Values of k', calculated from slopes of log A versus time graphs multiplied by (-2.303) for different methimazole concentrations 
Concentration (M) k΄ (s-1) 
8.76 × 10 -0.01863 -6 
1.31 × 10 -0.01652 -5 
1.75 × 10 -0.0187 -5 
2.19 × 10 -0.01565 -5 
2.63 × 10 -0.01691 -5 
 
Table 2: Values of slopes of initial tangents for different methimazole concentrations 
Concentration (M) Slope (s-1) 
8.76 × 10 0.00597 -6 
1.31 × 10 0.01055 -5 
1.75 × 10 0.01162 -5 
2.19 × 10 0.01745 -5 
2.63 × 10 0.02077 -5 
 
A calibration curve was constructed by plotting the logarithm of the 
initial rates (ΔA/Δt) versus the logarithm of the concentration, and 
gave the equation:  
log ϑ = 1.103 log C + 3.367        r = 0.971 
The value of the correlation coefficient (r) indicates poor linearity 
suggesting that the first step is too fast and not rate-determining, in 
addition, the graphs were not easy to plot. 
Fixed absorbance method 
It was performed by measuring the time required for 
methimazole concentration to reach an absorbance of a pre-
selected value (0.45) as it gives the widest calibration range. The 
reciprocals of time (1/Δt) were plotted against the initial 
concentration of methimazole. The regression equation was 
obtained (table 3). 
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Table 3: Values of 1/Δt taken at fixed absorbance (0.45) for different methimazole concentrations 
Δt (s) 1/Δt (s-1 Conc. (M) ) Regression equation Regression coefficient 
990 0.00101 1.31 × 10 1
Δ𝑡𝑡
= 2033𝐶𝐶 − 0.026 
-5 r = 0.989 
126 0.007937 1.75 × 10
60 
-5 
0.016667 2.19 × 10
36 
-5 
0.027778 2.63 × 10-5 
The value of the correlation coefficient indicates poor linearity, and therefore this method cannot be used. 
 
Fixed time method 
It was performed by measuring the absorbance value of the reaction 
solution containing different methimazole concentrations at a pre-
selected fixed time, which was accurately determined. Calibration 
graphs of absorbance value versus initial concentration of 
methimazole were established at fixed times of 2, 5, 10, 15, 20, 25, 
30 and 35 min (table 4). 
 
Table 4: Regression equations at different fixed times for methimazole in the concentration range of 0.25-3 µg/ml 
Time (min) Regression equation Correlation coefficient 
2 y = 0.208x+0.011 0.983 
5 y = 0.244x-0.008 0.987 
10 y = 0.279x-0.004 0.990 
15 y = 0.285x+0.015 0.982 
20 y = 0.298x+0.009 0.989 
25 y = 0.308x+0.009 0.993 
30 y = 0.320x-0.001 0.999 
35 y = 0.322x+0.001 0.995 
 
The slope is increasing with time while the intercept is decreasing. 
The most acceptable value of the correlation coefficient was 
obtained after a fixed time of 30 min; hence the time of 30 min was 
chosen as the most suitable time for measurement and calibration 
construction. Therefore, the fixed time method was the kinetic 
method selected to calculate the concentration of methimazole 
through its oxidation. 
Method validation 
Linearity, concentration range, the limit of detection and limit 
of quantitation  
Under the optimum reaction conditions, the standard calibration 
curve was constructed. The linear regression equations were 
obtained by the least-squares method; a linear correlation was 
found between the absorbance value at λmax
Linearity parameters including the correlation coefficient, 
intercept and slope for the calibration data are summarized in 
 and methimazole 
concentration.  
table 5. For accurate determination, sensitivity parameters such 
as apparent molar absorptivity and Sandell’s sensitivity values, 
as well as the limits of detection and quantification, were 
calculated as per the current ICH guidelines [41] and illustrated 
in table 5.  
Statistical data suggest the methods to be highly sensitive; reflected 
by the high molar absorptivity and low Sandell sensitivity values. 
 
Table 5: Assay parameters for the spectrophotometric determination of methimazole 
Parameter Method A Method B 
λ 610 nm max 507 nm 
Beer’s law limits (µg/ml) 1.5-15 0.25-3 




LOD(µg/ml) 0.466 0.05 
LOQ(µg/ml) 1.413 0.15 
Regression equation   
Intercept (a)±SD -0.00815 -0.00126 
Slope (b)±SD 0.059455 0.3205 
Correlation coefficient (r) 0.9993 0.9998 
S 0.0078 a 0.0045 
S 0.0008 b 0.0023 
S 0.0084 y/x 0.0048 
 
Accuracy and precision  
The accuracy of the methods was determined by calculating the % 
recovery of methimazole using the standard addition method at 
three different concentration levels within the linearity range. 
Percentage recoveries were then calculated and summarized in table 
6 for method A and in table 7 for method B. The obtained % 
recoveries show that the method has adequate accuracy. 
The precision of the method was expressed in the form of inter-and 
intra-day as percentage relative standard deviation (% RSD) for a 
series of measurements. The precision of the method was verified by 
repeatability and intermediate precision studies. Repeatability 
studies were performed by analyzing three different standard 
solutions, three times each on the same day (intra-day analysis). The 
intermediate precision of the methods was checked by repeating 
studies on three different days (inter-day analysis). The results 
obtained in table 6 for method A and table 7 for method B show 
good precision of the method. 
Method application 
The applicability of the proposed methods was tested in the 
pharmaceutical formulation Tapazole® tablet. Satisfactory 
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percentage recovery was obtained with low % RSD (table 8). This 
indicates high accuracy and precision in the determination of 
methimazole in its commercial tablets. Table 8 represents a 
statistical comparison between the assay of methimazole in its 
tablets by the proposed methods and a reference method [21] by 
means of Student’s t-test for accuracy and F-tests for precision at 
95% confidence level. The calculated t and F values did not exceed 
the theoretical values, indicating any significant difference in 
accuracy and precision between the proposed method and the 
reference method [21]. 
 
Table 6: Accuracy and precision data for the spectrophotometric determination of methimazole in pure form with KMnO4 in alkaline 
medium 
 Methimazole taken (µg/ml) Methimazole found (µg/ml) % RSD % Recovery % Error 
Inter-day 5 5.01 6.67 100.20 0.20 
10 10.22 2.29 102.20 2.20 
15 14.95 2.01 99.67 0.33 
Intra-day 5 5.17 3.65 103.40 3.40 
10 10.05 0.87 100.50 0.50 
15 15.05 1.36 100.33 0.33 
 
Table 7: Accuracy and precision data for the determination of methimazole in pure form using the proposed spectrophotometric method 
 Methimazole taken (µg/ml) Methimazole found (µg/ml) %RSD % Recovery % Error 
Intra-day 1 1.017 2.906 101.70 1.70 
1.5 1.537 2.367 102.47 2.47 
2 2.050 2.010 102.50 2.50 
Inter-day 1 1.006 1.299 100.60 0.60 
1.5 1.544 3.008 102.93 2.93 
2 2.073 3.518 103.65 3.65 
 
Table 8: Determination of methimazole in pharmaceutical preparation using methods A and B 
 Method A Method B Reference method  [21] 
a 100.82±0.28  Mean % Recovery±SD 99.85±1.00 101.78±1.79 
b 0.28 %RSD 1.00 1.77 
c 0.82 Error 0.15 1.78 





amean±SD for five determinations, bRelative standard deviation, c
 
Relative error, **Theoretical values of t-and F-test at P=0.05 are 2.13 and 5.05, 
respectively 
CONCLUSION 
Two spectrophotometric colorimetric methods have been developed 
and validated for the analysis of methimazole. The quantification of 
methimazole through these two methods accomplishes the 
requirements of specificity, precision, and accuracy in order to be 
used for the quality control of pharmaceuticals. These methods can 
be applied for the quality control of methimazole based on the 
simplicity, applicability of the parameters, accessibility of the 
reagents employed and reasonably low time of analysis. The 
proposed methods based on redox reaction were able to quantify the 
studied drug in its pharmaceutical formulation without the 
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